Home/Filings/4/0001209191-20-047804
4//SEC Filing

Erbez Georgia 4

Accession 0001209191-20-047804

CIK 0001708493other

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 6:36 PM ET

Size

8.3 KB

Accession

0001209191-20-047804

Insider Transaction Report

Form 4
Period: 2020-08-18
Erbez Georgia
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2020-08-18$11.60/sh+2,098$24,3373,915 total(indirect: See footnote)
  • Purchase

    Common Stock

    2020-08-19$11.40/sh+5,000$57,0008,915 total(indirect: See footnote)
Holdings
  • Common Stock

    47,292
  • Common Stock

    (indirect: See footnote)
    6,700
Footnotes (2)
  • [F1]Shares indirectly held by Georgia Leigh Erbez Charles Schwab & Co Inc Cust IRA Contributory ("Georgia Erbez IRA Contributory"). The Reporting Person has beneficial ownership over these shares held by Georgia Erbez IRA Contributory.
  • [F2]Shares indirectly held by David Milan Erbez Charles Schwab & Co Inc Cust IRA Contributory ("David Erbez IRA Contributory"). The Reporting Person has beneficial ownership over these shares held by David Erbez IRA Contributory.

Issuer

Harpoon Therapeutics, Inc.

CIK 0001708493

Entity typeother

Related Parties

1
  • filerCIK 0001557930

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 6:36 PM ET
Size
8.3 KB